A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers (Q40057190)
Jump to navigation
Jump to search
scientific article published on 22 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers |
scientific article published on 22 October 2007 |
Statements
1 reference
A comparative study on the immunogenicity, safety and tolerance of purified duck embryo vaccine (PDEV) manufactured in India (Vaxirab) and Switzerland (Lyssavac-N): a randomized simulated post-exposure study in healthy volunteers (English)
1 reference
Bangalore Jayakrishnappa Mahendra
1 reference
Shampur Narayan Madhusudana
1 reference
Doddabele Hanumanthaiah Ashwathnarayana
1 reference
Gadey Sampath
1 reference
Soma Subhra datta
1 reference
Mysore Kalappa Sudarshan
1 reference
Gonibeedu Manjunatah Venkatesh
1 reference
Kader Muhamuda
1 reference
Gangaboraiah Bilagumba
1 reference
Manjula Shamanna
1 reference
22 October 2007
1 reference
1 reference
25
1 reference
50
1 reference
8405-8409
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference